Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

PURPOSE: We conducted a phase II trial to evaluate the efficacy and safety of single-agent sorafenib in chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN). The primary end point was response probability (ie, confirmed complete and partial re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Williamson, Stephen K., Moon, James, Huang, Chao H., Guaglianone, Perry P., LeBlanc, Michael, Wolf, Gregory T., Urba, Susan G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903329/
https://ncbi.nlm.nih.gov/pubmed/20498388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.6834
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados